Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alberto Barrientos-Guzmán"'
Autor:
Natividad N Calvo-Romero, Ana Sánchez-Fructuoso, Alberto Barrientos-Guzmán, Jose Luis Santiago, Isabel Pérez-Flores
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2013 (2013)
BioMed Research International, Vol 2013 (2013)
It is well know that anti-HLA antibodies are an important obstacle in kidney transplantation. Our aim was to study the clinical impact of pretransplant donor specific anti-HLA antibodies (HLA-DSA), in highly sensitized (HS) patients. We analyzed retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39a81e1392555882055bdd7455b34550
https://pubmed.ncbi.nlm.nih.gov/24093102
https://pubmed.ncbi.nlm.nih.gov/24093102
Autor:
Enrique A, Florit, Isabel, Ubeda-Aranda, Pablo, Delgado-Conde, Beatriz, Rodríguez-Cubillo, Tania, Monzón-Vázquez, José C, de la Flor Merino, Francisco, Valga-Amado, Alberto, Barrientos-Guzmán
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 32(2)
Psoriasis is a cutaneous disease with systemic involvement. Tissue damage is considered to be immune-mediated, and etanercept currently provides effective treatment. Kidney injury arising from this condition has not yet been fully explained in the li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef83c01fb626895bc099bb9c9fcb3e36
https://pubmed.ncbi.nlm.nih.gov/22421953
https://pubmed.ncbi.nlm.nih.gov/22421953
Autor:
Dolores Prats Sánchez, Alberto Barrientos Guzmán, Maria Marques Vidas, Ana Sánchez-Fructuoso, Eduardo López de Novales
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 19
Background. Several groups have demonstrated that non-heart beating donation is a viable source of organs for transplantation. However, the theoretically worse graft function and survival of the kidneys obtained from non-heart beating donors (NHBDs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48303e64fae9b65e8e159424f8e9d0e2
https://pubmed.ncbi.nlm.nih.gov/15192132
https://pubmed.ncbi.nlm.nih.gov/15192132
Since its discovery in 1984, Tacrolimus has proven itself to be an invaluable tool in the armamentarium of immunosuppression after organ transplantations. Tacrolimus was first introduced as a rescue therapy in liver transplant patients and quickly sh
